# Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )

> **NCT04815291** · NA · TERMINATED · sponsor: **Merit Medical Systems, Inc.** · enrollment: 93 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Receives SCOUT at biopsy

## Key facts

- **NCT ID:** NCT04815291
- **Lead sponsor:** Merit Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-01
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-01-15
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** Sponsor decision.
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815291, "Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04815291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*